APSR2026-726

 
Late-Breaking
Submitted
Oral Presentation
AO23-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1221168-46903-APSR26_Oral Presentation_APSR2026-726_AO23-001 (Final)_434691.pptx
Format: PPTX Only
 
Format: PDF Only
03. Clinical Allergy and Immunology
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

S Rishikesavan * National Hospital of Sri Lanka Consultant Respiratory Physician Colombo Sri Lanka
Raju Pangeni - HAMS Hospital Consultant Pulmonologist and Intensivist Kathmandu Nepal
Bodhika Samarasekera - District General Hospital Consultant Pulmonologist Negombo Sri Lanka
Pang Yong Kek - Universiti Malaya Associate Professor, Department of Medicine Kuala Lumpur Malaysia
Rajeev Chathanath - NMC Hospital, Ghoubra Consultant Physician Muscat Oman
Aniruddha Mukhopadhyay - Cipla Limited Global Medical Affairs Mumbai India
Jaideep Gogtay - Cipla Limited Global Medical Affairs Mumbai India
Vaibhav Gaur - Cipla Limited Global Medical Affairs Mumbai India
 
 
 
 
 
 
 
Presenting Author Details
S
Rishikesavan
aniruddha.mukhopadhyay@cipla.com
+919830061506
41-50
Sri Lanka
Original Research
Specialists vs. General Practitioners: Unveiling Key Differences in Diagnosing and Managing Comorbid Asthma and Allergic Rhinitis Across Four Asian Countries
Maximum 25 words
Abstract Content
Comorbid Asthma And Allergic rhinitis (CAAR) are prevalent across Asia. However, there is a paucity of data regarding the diagnosis and management of CAAR. The study aimed to compare the experiences and assessments of specialists vs. general practitioners on diagnosing and managing patients with CAAR.
This cross-sectional, observational survey compared the experiences of 111 specialists (pulmonologists, physicians and ENTs) and 114 general practitioners from 95 cities across four Asian countries (Sri Lanka, Nepal, Malaysia, and Oman).
Specialists saw and managed more cases of perennial allergic rhinitis (AR) (22% vs. 17%), post-nasal drip (28% vs. 22%), and nasal polyps (15% vs. 10%) compared with general practitioners. Moreover, nearly two-thirds of specialists (63% vs. 40% of general practitioners) believed that AR was detected first in patients with CAAR. Specialists are more likely to order regular skin prick tests (8%) and serum IgE (47%) compared with general practitioners (3% and 11%, respectively). For diagnosis of asthma, specialists (48% vs. 14% general practitioners) relied on clinical evaluation supported by spirometry testing, whereas more general practitioners (62% vs. 38% specialists) relied solely on clinical assessment. In CAAR both specialists and general practitioners preferred to follow up patients every three months and equally preferred managing asthma and AR simultaneously along with concomitant administration of inhaled corticosteroid (ICS) and intra-nasal corticosteroid (INCS). More specialists (62% vs. 28% general practitioners) prescribed INCS to all CAAR patients, and (61% specialists vs. 54% general practitioners) believed that managing only asthma or only AR can negatively affect patients’ comorbid condition.
The survey highlights differences in the diagnostic and management practices of specialists and general practitioners for CAAR. Proper diagnosis of CAAR and its management with ICS and INCS can help general practitioners treat patients with both asthma and allergic rhinitis more effectively.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma, Allergic Rhinitis, Comorbidity
maximum 3 keywords and no abbreviations, separated by commas
 
291